Upadacitinib Shows Strong Efficacy in Phase 3 Alopecia Areata Trial
Written by
American Journal Managed Care
Published
0
comments
0
min
The trial is one of 2 phase 3 studies of upadacitinib in patients with severe alopecia areata.